Topical imiquimod therapy for cutaneous T-cell lymphoma.

about

Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma Therapeutic advances in cutaneous T-cell lymphoma

P2860

Q36070459-02D20542-567D-409E-973B-A94FE82F182D Q37876869-DD1F8D8C-312B-4411-A574-9F3A15250046

P2860

Topical imiquimod therapy for cutaneous T-cell lymphoma.

Item

http://www.wikidata.org/entity/Q44691746

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Topical imiquimod therapy for cutaneous T-cell lymphoma.

@en

Topical imiquimod therapy for cutaneous T-cell lymphoma.

@nl

type

Item

label

Topical imiquimod therapy for cutaneous T-cell lymphoma.

@en

Topical imiquimod therapy for cutaneous T-cell lymphoma.

@nl

prefLabel

Topical imiquimod therapy for cutaneous T-cell lymphoma.

@en

Topical imiquimod therapy for cutaneous T-cell lymphoma.

@nl

P1476

Topical imiquimod therapy for cutaneous T-cell lymphoma.

@en

P2093

Anthony A Gaspari

http://www.w3.org/2001/XMLSchema#string

Jennifer H Do

http://www.w3.org/2001/XMLSchema#string

Susan S McLaughlin

http://www.w3.org/2001/XMLSchema#string

P2860

Imiquimod in clinical practice.

Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.

Oral bexarotene in the treatment of cutaneous T-cell lymphoma.

Cutaneous T-cell lymphoma. New immunomodulators.

Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.

Topical 5% imiquimod for the therapy of actinic cheilitis.

Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis.

Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.

The effect of indomethacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells.

Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.

P304

316-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1540-9740.2003.02258.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14673267

http://www.w3.org/2001/XMLSchema#string

Topical imiquimod therapy for cutaneous T-cell lymphoma.

about

P2860

P2860

Topical imiquimod therapy for cutaneous T-cell lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698